Current Australian practice in the prevention and management of corneal allograft rejection

Nigel H. Barker, Timothy R.M. Henderson, Carolyn A. Ross, Douglas J. Coster, Keryn A. Williams

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)


Purpose: To determine current practice in the prevention and management of corneal allograft rejection in Australia. Methods: A questionnaire was circulated to attendees at the 1998 Eye Bank Meeting in Adelaide. Twenty-four responses were received and analysed. Results: All respondents used topical corticosteroids for routine prophylaxis and to treat established rejection episodes. Prednisolone acetate was the most frequently prescribed topical corticosteroid. Systemic non-steroidal immunosuppression was prescribed almost exclusively for high-risk grafts. Seventy-five per cent of surgeons used systemic antiviral agents for the treatment of graft rejection in patients with Herpes simplex keratitis. Conclusion: There was a wide variation amongst surgeons in the choice of therapy for routine prophylactic immuno-suppression as well as for the treatment of established corneal allograft rejection.

Original languageEnglish
Pages (from-to)357-360
Number of pages4
JournalClinical and Experimental Ophthalmology
Issue number5
Publication statusPublished or Issued - 2000


  • Antiviral agents
  • Corneal graft rejection
  • Corticosteroids
  • Immunosuppression
  • Penetrating keratoplasty

ASJC Scopus subject areas

  • Ophthalmology

Cite this